CTOs on the Move

Tradiverse

www.tradiverse.com

 
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Happy Egg

Taste the joy of healthy, Happy eggs.

Pepsi-Cola Bottling Company of Central Virginia

Pepsi-Cola Bottling Company of Central Virginia (PCVA) is the operator of the oldest recorded Pepsi-Cola Bottling franchise in the United States and is licensed to manufacture and sell its products within a specified region in the State of Virginia.

Blake Farms

70 years and counting! Were so proud to have served the Metro Detroit community since 1946. With 3 family-owned orchards, a cider mill, and 10,00 square feet of greenhouses, weve grown a little since our beginnings--thanks only to you! Our season...

OBI Seafoods

OBI Seafoods is an Alaskan seafood processor with ten shoreside plants producing fresh & frozen seafood and canned salmon. The product of a merger between Ocean Beauty Seafoods and Icicle Seafoods, OBI Seafoods is one of the largest Alaska seafood processors with over 100 years of processing history and experience. Our processing facilities are located in Petersburg, Excursion Inlet, Cordova, Seward, Kodiak, Larsen Bay, Alitak, Egegik, Wood River (Dillingham) and Naknek. We process a variety of species including salmon, halibut, black cod (sablefish), Pacific cod, crab, herring and whitefish.

Neptune Technologies and Bioressources

Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.